✦ LIBER ✦

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice

✍ Scribed by Mary A Hoelscher; Sanjay Garg; Dinesh S Bangari; Jessica A Belser; Xiuhua Lu; Iain Stephenson; Rick A Bright; Jacqueline M Katz; Suresh K Mittal; Suryaprakash Sambhara

Book ID: 117985680
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 176 KB
Volume: 367
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(06)68076-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of an AS03A-adjuvanted split H5

Efficacy of an AS03A-adjuvanted split H5N1 influenza vaccine against an antigenically distinct low pathogenic H5N1 virus in pigs

✍ Annebel R. De Vleeschauwer; Benoît Baras; Constantinos S. Kyriakis; Valérie Jaco 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Protective efficacy of an H1N1 cold-adap

Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice

✍ Jianzhong Shi; Zhiyuan Wen; Jing Guo; Ying Zhang; Guohua Deng; Yuelong Shu; Daya 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 831 KB

Inactivated and adjuvanted whole-virion

Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice

✍ Yuichi Harada; Ai Ninomiya-Mori; Yoshimasa Takahashi; Masayuki Shirakura; Noriko 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 421 KB